Duchenne Muscular Dystrophy: A Practice Update
- 359 Downloads
Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder caused by a deficient or defective synthesis of dystrophin protein. DMD is the most common form of muscular dystrophy with an incidence of about 1 in 5000 live boys. Though primarily resulting in progressive muscle weakness, it affects various other organs as well. Heart, brain and smooth muscles are commonly involved, because of expression of dystrophin in these organs. The management of DMD requires a multidisciplinary liaison, anticipatory management and prevention of the complications. Consensus based international recommendation for management of DMD have been published in the year 2010, recognizing DMD as a multi-systemic and progressive disease. The proper management of a boy with DMD can improve ambulation, independence, quality of life and delay disease – related complications. A lot can be done to comfort affected children and their care givers even in a resource limited setting. This review discusses these options and also the current understanding of the disease.
KeywordsMyopathy Muscle disease Rehabilitation Genetic
RS: Reviewed the literature and drafted the manuscript, NS: Edited the manuscript for intellectual content, approved the final version and will act as guarantor for the paper.
Compliance with Ethical Standards
Conflict of Interest
Source of Funding
- 11.Darras BT, Menache-Starobinski CC, Hinton V, Kunkel LM. Dystrophinopathies. In: Darras BT, editor. Neuromuscular disorders of infancy, childhood and adolescence: a clinicians approach. 2nd ed. London, UK: Elesevier; 2015. p. 551–92.Google Scholar
- 18.Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;5:CD003725.Google Scholar